Innovative therapies
Showing 1 - 25 of >10,000
Triple-negative Breast Cancers in Order to Validate Interest of
Not yet recruiting
- Triple Negative Breast Cancer
- Organoid
- Establishment of ex vivo breast cancer organoid models
-
Caen, FranceCentre François Baclesse
Aug 9, 2022
APOLLO 11, Consortium of Italian Centers Involved in Treatment
Not yet recruiting
- NSCLC
- +4 more
- (no location specified)
Sep 19, 2022
Diffuse Intrinsic Pontine Glioma, Diffuse Midline Glioma, H3 K27M-Mutant Trial in Villejuif (Everolimus, ONC201, Radiotherapy)
Not yet recruiting
- Diffuse Intrinsic Pontine Glioma
- Diffuse Midline Glioma, H3 K27M-Mutant
- Everolimus
- +2 more
-
Villejuif, Val De Marne, FranceGustave Roussy
Jul 27, 2022
Spinal Muscular Atrophy Trial in Paris (Motor function measurement using inertial sensors)
Not yet recruiting
- Spinal Muscular Atrophy
- Motor function measurement using inertial sensors
-
Paris, FranceHôpital Necker-Enfants Malades
Jun 26, 2021
Constitution of ex Vivo Ovarian Tumor Models for Validation of
Recruiting
- Ovarian Cancer
- collection of blood, urine, tumor and ascite samples
-
Caen, FranceCentre François BACLESSE
Jul 20, 2021
Acute Lymphoblastic Leukemia, Lymphoblastic Lymphoma (Precursor B-Lymphoblastic Lymphoma/Leukaemia) Recurrent, Lymphoblastic
Not yet recruiting
- Acute Lymphoblastic Leukemia
- +4 more
- Dasatinib
- +5 more
-
Utrecht, NetherlandsPrincess Máxima Center for Pediatric Oncology
Feb 20, 2023
Acute Lymphoblastic Leukemia, in Relapse, Lymphoblastic Lymphoma (Precursor B-Lymphoblastic Lymphoma/Leukaemia) Recurrent,
Not yet recruiting
- Acute Lymphoblastic Leukemia, in Relapse
- +4 more
- Ruxolitinib
- +5 more
-
Utrecht, NetherlandsPrincess Máxima Center for Pediatric Oncology
Feb 16, 2023
Acute Lymphoblastic Leukemia, in Relapse, Lymphoblastic Lymphoma (Precursor B-Lymphoblastic Lymphoma/Leukaemia) Recurrent,
Not yet recruiting
- Acute Lymphoblastic Leukemia, in Relapse
- +4 more
- Decitabine
- +3 more
-
Utrecht, NetherlandsPrincess Máxima Center for Pediatric Oncology
Feb 22, 2023
Type 1 Diabetes Trial in New Haven (Follicular Euglycemic clamp, Luteal Euglycemic clamp)
Completed
- Type 1 Diabetes
- Follicular Euglycemic clamp
- Luteal Euglycemic clamp
-
New Haven, ConnecticutYale University School of Medicine
Feb 9, 2022
Acute Lymphoblastic Leukemia, in Relapse, Lymphoblastic Lymphoma (Precursor B-Lymphoblastic Lymphoma/Leukaemia) Recurrent,
Not yet recruiting
- Acute Lymphoblastic Leukemia, in Relapse
- +4 more
- Trametinib
- +4 more
-
Utrecht, NetherlandsPrincess Máxima Center for Pediatric Oncology
Dec 13, 2022
Neuroblastoma Trial in Worldwide (LY3295668 Erbumine, Topotecan, Cyclophosphamide)
Active, not recruiting
- Neuroblastoma
- LY3295668 Erbumine
- +2 more
-
San Francisco, California
- +21 more
Aug 17, 2022
Esophageal Squamous Cell Carcinoma (ESCC) Trial in Japan, Taiwan (Pembrolizumab, Coformulation favezelimab/pembrolizumab,
Recruiting
- Esophageal Squamous Cell Carcinoma (ESCC)
- Pembrolizumab
- +5 more
-
Milan, Lombardia, Italy
- +13 more
Jan 3, 2023
Relapsed or Refractory Pediatric Tumor Trial in Worldwide (biopsy or surgical resection of tumor and blood sampling)
Unknown status
- Relapsed or Refractory Pediatric Tumor
- biopsy or surgical resection of tumor and blood sampling
-
Villejuif, Val De Marne, France
- +4 more
Feb 14, 2020
Uterine Cervical Tumors, Endometrial Tumors, Squamous Cell Carcinoma of Head and Neck Trial in Worldwide
Recruiting
- Uterine Cervical Neoplasms
- +10 more
- Pembrolizumab/Vibostolimab Co-Formulation
- +11 more
-
Anchorage, Alaska
- +65 more
Jan 27, 2023
Sleep Apnea, SCI/D, Hypercapnia Trial in Detroit (Hypercapnia treatment, Sham treatment)
Not yet recruiting
- Sleep Apnea
- +2 more
- Hypercapnia treatment
- Sham treatment
-
Detroit, MichiganJohn D. Dingell VA Medical Center, Detroit, MI
Sep 9, 2022
Including miRNA-based Tumor Signatures in Diffuse Large B Cell
Not yet recruiting
- Diffuse Large B Cell Lymphoma
- Relapsed Non-Hodgkin Lymphoma
- no intervention (observational study)
-
Napoli, Italy
- +2 more
Feb 17, 2023
Healthy (For Part A), Chronic Myeloid Leukemia (for Part B and C) Trial in Worldwide (Vodobatinib (K0706) capsules)
Recruiting
- Healthy (For Part A)
- Chronic Myeloid Leukemia (for Part B and C)
- Vodobatinib (K0706) capsules
-
Downey, California
- +69 more
Dec 7, 2022
Therapeutic Monitoring of Infliximab and Adalimumab
Recruiting
- Inflammatory Bowel Diseases
-
Trieste, ItalyIRCCS Burlo Garofolo
Sep 5, 2023
Nonsmall Cell Lung Cancer, NSCLC Trial in Worldwide (NovoTTF-200T, Immune checkpoint inhibitors or docetaxel)
Active, not recruiting
- Nonsmall Cell Lung Cancer
- NSCLC
- NovoTTF-200T
- Immune checkpoint inhibitors or docetaxel
-
Birmingham, Alabama
- +123 more
Oct 13, 2022
Acute Lymphoblastic Leukemia (ALL) Trial in Worldwide (Carfilzomib, Dexamethasone, Mitoxantrone)
Recruiting
- Acute Lymphoblastic Leukemia (ALL)
- Carfilzomib
- +10 more
-
Orange, California
- +86 more
Nov 14, 2022
Type 1 Diabetes, Type 2 Diabetes Trial in Boston (Diabetes Collaborative Care Model for Young Adults, Usual Care Model)
Active, not recruiting
- Type 1 Diabetes
- Type 2 Diabetes
- Diabetes Collaborative Care Model for Young Adults
- Usual Care Model
-
Boston, MassachusettsMassachusetts General Hospital
Dec 20, 2022